was tirzepatide taken off the market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with The Tirzepatide Shortage Is Over:

Subcutaneous semaglutide was FDA approved as Ozempic to treat type 2 diabetes in 2017

The most frequently reported issues include: Nausea : 21.49% of patients Diarrhea : 10.62% Vomiting : 9.10% Dyspepsia (indigestion) : 8.67% Constipation : 7.92% Decreased appetite : 5.49% While many tolerate these medications well, over 10% of patients stop or interrupt treatment due to severe discomfort

Maybe it is for you

Drinking 2.53 liters of water dailyspread throughout the dayreduces these discomforts while supporting kidney function and metabolic efficiency

However, dizziness that occurs at rest or wakes you from sleep may signal a cardiovascular response that warrants evaluation